Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 3, 2006, Pages 325-330

  Appetecchia, Marialuisa ^a   Bacaro, D ^b   Brigida, R ^b   Milardi, D ^c   Bianchi, A ^c   Solivetti, F ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Contrast enhanced ultrasound; Second generation contrast agents; Thyroid nodules

Indexed keywords

CONTRAST MEDIUM; SULFUR HEXAFLUORIDE; TECHNETIUM 99M;

ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CYSTADENOMA; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SCINTISCANNING; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROIDITIS;

ADENOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; PILOT PROJECTS; THYROID NEOPLASMS; THYROID NODULE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33751114950     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ross D.S.: Evaluation of the thyroid nodules. J. Nucl. Med. 32: 2181, 1991.
2. Rago T., Vitti P., Chiovato L., et al.: Role of conventional ultrasonography and color flow doppler sonography in predicting malignancy in "cold" thyroid nodules. European Journal of Endocrinology 138, 41-46, 1998.
3. Cerbone G., Spiezia S., Colao A. et al.: Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow up results. Horm. Res. 52(1), 19-24, 1999.
4. Papini E., Guglielmi R., Bianchini A. et al.: Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J. Clin. Endocrinol. Metab. 87(5), 1941-1949, 2002.
5. Cosgrove D.: Ultrasound contrast enhancement of tumors. Clinical. Radiol. 1: 44-49, 1996.
6. Tessler F.N., Tublin M.E.: Thyroid sonography: current applications and future directions. J. Clin. Ultrasound 173: 437-443, 1999.
7. Clark K.J., Cronan J.J., Scola F.H.: Color doppler sonography: anatomic and physiologic assessment of the thyroid. J. Clin. Ultrasound 23: 215-223, 1995.
8. Naruo K., Miyamoto Y., Tada S.: Diagnosis of thyroid nodules by Doppler ultrasonography: a comparison between color Doppler and power Doppler ultrasonography. Nippon Igaku Hoshasen Gakkai Zasshi 59: 3-11, 1999.
9. Kawauchi A., Hashimoto Y., Kamiya K., Hattori Kusano M. Contrast echo imaging on the breast and thyroid cancers. Nippon Rinsho 56: 1049-105, 1998.
10. Spiezia S., Farina R., Cerbone G., et al.: Analysis of color doppler signal intensity variation after Levovist injection. J. Ultrasound Med. 20: 223-231, 2001.
11. Calliada F., Pallavicini D., Pasamonti M., et al.: Topical role and future perspectives of sonographic contrast agents in the differential diagnosis of solid thyroid lesions. Rays 25: 191-197, 2000.
12. Solbiati L., Tonolini M., Cova L. et al.: The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur. Radiol. 11 Suppl 3:E15-26, 2001.
13. Gorg C., Bert T.: Contrast enhanced sonography of focal splenic lesions with a second-generation contrast agent. Ultraschall Med. 26(6):470-477, 2005.
14. Seeler D., von Klinggraff G., Christl S.U.: Sonographic detection of kidney infarctions using ultrasound contrast media. Ultraschall Med. 26(6):518-523, 2005.
15. Poletti P.A., Platon A., Becker C.D., et al. Blunt abdominaltrauma: does the use of a second-generation sonographic contrast agent help to detect solid organ injuries? AJR Am. J. Roentgenol. 183(5):1293-1301, 2004.
16. Madjar H.: Contrast ultrasound in breast tumor characterization: present situation and future tracks. Eur. Radiol. 11 Suppl 3:E41-46, 2001.